Immunogene Therapy Against Mouse Leukemia Using B7 Molecules

Cancer Gene Therapy - United Kingdom
doi 10.1038/sj.cgt.7700099
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Regulation of T Cell Activation by B7 Molecules.

SEIBUTSU BUTSURI KAGAKU
1995English

AdCD40L Immunogene Therapy for Bladder Carcinoma--The First Phase I/IIa Trial

Clinical Cancer Research
Cancer ResearchOncology
2010English

Expression of B7 Co-Stimulatory Molecules by B16 Melanoma Results in a Natural Killer Cell-Dependent Local Anti-Tumour Response, but Induces T-Cell-Dependent Systemic Immunity Only Against B7-Expressing Tumours

British Journal of Cancer
Cancer ResearchOncology
1998English

Vaccination With Mouse Mammary Adenocarcinoma Cells Coexpressing B7-1 (CD80) and B7-2 (CD86) Discloses the Dominant Effect of B7-1 in the Induction of Antitumor Immunity

Journal of Immunology
AllergyImmunology
2000English

The Expression of B7-H1 and B7-H4 Molecules on Immature Myeloid and Lymphoid Dendritic Cells in Cord Blood of Healthy Neonates.

Folia Histochemica et Cytobiologica
MedicineForensic MedicinePathologyHistology
2011English

Prevention of Angiogenesis by Naked DNA IL-12 Gene Transfer: Angioprevention by Immunogene Therapy

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2004English

Expression of B7-Family Co-Inhibitory Molecules by Dendritic Cells From Pancreatic Cancer Patients

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Genetic Aspects of Mouse Leukemia

The American Journal of Cancer
1936English

Transcriptome Profiling of Mouse Samples Using Nanopore Sequencing of cDNA and RNA Molecules

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy